Smith Shellnut Wilson’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$570K Hold
4,435
0.21% 80
2026
Q1
$533K Buy
4,435
+168
+4% +$19.4K 0.23% 73
2025
Q4
$449K Buy
4,267
+750
+21% +$70.4K 0.17% 86
2025
Q3
$295K Buy
3,517
+478
+16% +$39.4K 0.11% 112
2025
Q2
$241K Hold
3,039
0.1% 120
2025
Q1
$273K Hold
3,039
0.13% 115
2024
Q4
$302K Hold
3,039
0.13% 106
2024
Q3
$345K Sell
3,039
-200
-6% -$23.8K 0.16% 100
2024
Q2
$401K Hold
3,239
0.19% 83
2024
Q1
$427K Sell
3,239
-200
-6% -$24.7K 0.23% 80
2023
Q4
$375K Hold
3,439
0.22% 84
2023
Q3
$354K Hold
3,439
0.22% 80
2023
Q2
$397K Sell
3,439
-110
-3% -$12.5K 0.22% 78
2023
Q1
$378K Hold
3,549
0.23% 75
2022
Q4
$394K Hold
3,549
0.24% 72
2022
Q3
$306K Hold
3,549
0.2% 84
2022
Q2
$324K Hold
3,549
0.2% 91
2022
Q1
$291K Sell
3,549
-1,148
-24% -$90.5K 0.15% 115
2021
Q4
$360K Buy
4,697
+758
+19% +$60.4K 0.18% 107
2021
Q3
$296K Buy
3,939
+1,252
+47% +$95.2K 0.17% 110
2021
Q2
$209K Sell
2,687
-129
-5% -$9.6K 0.12% 130
2021
Q1
$207K Buy
2,816
+115
+4% +$8.48K 0.13% 127
2020
Q4
$211K Buy
2,701
+155
+6% +$11.9K 0.13% 125
2020
Q3
$201K Buy
+2,546
New +$199K 0.08% 121

Other funds holding MRK

Smith Shellnut Wilson's MRK Position: Q2 2026 in Review

Smith Shellnut Wilson held its Merck (MRK) position steady in Q2 2026 at 4,435 shares worth $570K. The position accounts for 0.21% of the portfolio, ranked #80.

Smith Shellnut Wilson first reported a position in MRK in Q3 2020 and has held it in 24 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Smith Shellnut Wilson held 4,435 shares of Merck worth $570K as of Q2 2026.
  • Smith Shellnut Wilson left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.21% of Smith Shellnut Wilson's portfolio in Q2 2026, its #80 holding.
  • Smith Shellnut Wilson first reported a position in Merck in Q3 2020 and has held it in 24 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Smith Shellnut Wilson's 13F filing for Q2 2026, filed 3 Aug 2026.